Market Growth Position AnimalBiome as a leader in pet microbiome health with a multi-product portfolio spanning diagnostic testing, gut health restoration, and immune-supportive treats to address growing pet owner demand for science-backed wellness solutions.

Partnerships & Ecosystem Leverage existing and potential partnerships with veterinary practices, pet food brands, and biotech collaborators (e.g., Embark) to expand distribution, co-branding opportunities, and integrated offering for clinics and direct-to-consumer channels.

Product Expansion Target expansion into durable consumer-facing formats and pet foods (e.g., Fish Bits) and ongoing research (FMT, immune-supportive products) to introduce recurring revenue streams through subscriptions and cross-sell across clinics and households.

Geographic & Vet Channel Emphasize veterinarians and international markets as growth vectors, highlighting VET-only platforms and global pet wellness initiatives to penetrate clinics, specialty practices, and international distribution partners.

Financial Momentum Capitalize on a mid-market revenue profile and proven market traction (State of the Gut reports, product launches, and $12M+ funding) to pursue strategic investors, channel partners, and larger veterinary networks seeking scalable microbiome solutions.